---
figid: PMC6956866__CMAR-12-79-g0003
figtitle: Pue for different pathways
organisms:
- Nicotiana tabacum
- Candida dubliniensis
- Hordeum vulgare
- Vicia faba
- Actaea cimicifuga
- Pueraria montana var. lobata
- Pueraria tuberosa
- Pueraria montana var. thomsonii
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC6956866
filename: CMAR-12-79-g0003.jpg
figlink: pmc/articles/PMC6956866/figure/F0003/
number: F3
caption: Schematic of Pue for different pathways. (A) Pue inhibits cancer cell proliferation,
  migration, and adhesion through the NF-kB and AMPK pathways. In NF-kB, Pue inhibits
  TNF-α, TRL-4, IKKβ, IkBα, and NF-kB translocation from the cytoplasm to the nucleus,
  which further inhibits COX-2, MMP-2,9, CXCR4, CCR7, VCAM, and ICAM. In the AMPK
  pathway, Pue activates AMPK, ACC, and GSK-3b, which further inhibit CRE and MDR1.
  (B) Pue inhibits tumor growth and inflammation through activation of M1 markers,
  including iNOS, CD197+, and CD40+, inhibit M2 markers, including CD163+, Arg-1+,
  and CD206+. Furthermore, Pue activates IFN-g, TNF-α, and IL-12 and inhibits IL-10,
  IL-4, and TGF-β. (C) Pue inhibits the Akt and ERK expression, increases the Atg-5
  expression, and LC3I conversion to LC3II, as a result induces autophagy.
papertitle: Molecular Mechanisms of Anticancer Activities of Puerarin.
reftext: Bashir Ahmad, et al. Cancer Manag Res. 2020;12:79-90.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9620881
figid_alias: PMC6956866__F3
figtype: Figure
redirect_from: /figures/PMC6956866__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6956866__CMAR-12-79-g0003.html
  '@type': Dataset
  description: Schematic of Pue for different pathways. (A) Pue inhibits cancer cell
    proliferation, migration, and adhesion through the NF-kB and AMPK pathways. In
    NF-kB, Pue inhibits TNF-α, TRL-4, IKKβ, IkBα, and NF-kB translocation from the
    cytoplasm to the nucleus, which further inhibits COX-2, MMP-2,9, CXCR4, CCR7,
    VCAM, and ICAM. In the AMPK pathway, Pue activates AMPK, ACC, and GSK-3b, which
    further inhibit CRE and MDR1. (B) Pue inhibits tumor growth and inflammation through
    activation of M1 markers, including iNOS, CD197+, and CD40+, inhibit M2 markers,
    including CD163+, Arg-1+, and CD206+. Furthermore, Pue activates IFN-g, TNF-α,
    and IL-12 and inhibits IL-10, IL-4, and TGF-β. (C) Pue inhibits the Akt and ERK
    expression, increases the Atg-5 expression, and LC3I conversion to LC3II, as a
    result induces autophagy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tnf
  - Prkaa2
  - Il10
  - Il4
  - Nos2
  - Cd40
  - Ifng
  - Cd163
  - Arg1
  - Il12b
  - Nfkb1
  - Syt1
  - Abcb1b
  - Ephb1
  - Akt1
  - Mmp9
  - Mmp2
  - Ptgs2
  - Ccr7
  - Cxcr4
  - Icam1
  - Anxa3
  - Atg5
  - TNF
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - IL10
  - IL4
  - NOS2
  - ISYNA1
  - CCR7
  - CD40
  - IFNG
  - CD163
  - ARG1
  - TINAGL1
  - MRC1
  - ACACA
  - BMS1
  - ACACB
  - IL12A
  - IL12B
  - GSK3A
  - GSK3B
  - NFKBIA
  - NFKB1
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - ABCB1
  - TBC1D9
  - EPHB2
  - MAPK1
  - MAPK3
  - AKT1
  - AKT2
  - AKT3
  - MMP9
  - MMP2
  - PTGS2
  - CXCR4
  - ICAM1
  - ICAM2
  - ICAM3
  - ICAM4
  - ICAM5
  - MAP1LC3A
  - ATG5
  - Tbrs4
  - Tinagl1
  - Mrc1
  - Acc
  - Gsk3b
  - Rela
  - Gorasp1
  - Mod2
  - Ephb2
  - Mapk1
  - Map1lc3a
  - tnfb
  - il10
  - il13
  - il4
  - nos1
  - cd40
  - ifng1
  - cd63
  - arg1
  - acaca
  - gsk3ba
  - gsk3ab
  - rela
  - abcb5
  - mmp9
  - mmp2
  - COX2
  - ccr7
  - cxcr4b
  - b3gnt5a
  - atg5
  - Puerarin
  - Arg
  - BEZ235
---
